MyAverix Finance MyAverix Finance

US · Healthcare

RaySearch Laboratories AB (publ) (RSLBF)

Health Information Services

RaySearch Laboratories AB (publ) (RSLBF) is listed on US in the Healthcare sector. Industry: Health Information Services. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-23

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for RSLBF

P/E ratio
18.00

RaySearch Laboratories AB (publ) (RSLBF) — FAQ

What is RSLBF's P/E ratio?

The price-to-earnings (P/E) ratio for RaySearch Laboratories AB (publ) (RSLBF) is 18.00 (data as of 2026-05-23).

Does RaySearch Laboratories AB (publ) pay a dividend?

Dividend yield is not available in the current snapshot for RaySearch Laboratories AB (publ) (RSLBF). Check the MyAverix Finance app for the latest dividend data.

What sector is RaySearch Laboratories AB (publ) in?

RaySearch Laboratories AB (publ) (RSLBF) is classified in the Healthcare sector (Health Information Services industry).

What exchange is RSLBF listed on?

RSLBF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play